Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma

This study has been completed.
Sponsor:
Collaborator:
Advance Biofactures Corporation
Information provided by (Responsible Party):
Zachary Gerut, Gerut, Zachary, M.D.
ClinicalTrials.gov Identifier:
NCT01613313
First received: June 5, 2012
Last updated: February 4, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2013
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)